Co gamma rays/Mouse small eye mutant/Pax6
INTRODUCTION
It is well known that leukemia occurs more frequently among atomic bomb survivors than in the general population. [1] [2] [3] Clinical, cytogenetic, and molecular-genetic examinations indicated that complex chromosome abnormalities without a specific type of translocation and a high incidence of genetic instability of leukemic cells were characteristic to radiation-related acute myeloid leukemia in humans. 4) To clarify the mechanism of leukemogenesis, the experimental model is useful. Hayata et al. reported the high susceptibility of C3H/He mice to myeloid leukemia and the consistent occurrence of the deleted chromosome 2 in mouse myeloid leukemias. 5, 6) Since this publication, there have been three independent articles that demonstrated the occurrence of the deleted chromosome 2 in mouse radiation-induced acute myeloid leukemia). [7] [8] [9] Alexander et al. reported the commonly deleted region of 6.5 cM from markers D2Mit214 to D2Mit395, where Wt1 and Pax6 genes located. 7) Silver et al. reported the minimal deleted region for radiation-induced acute myeloid leukemia on chromosome 2.
8) The interval was 1 cM between markers D2Mit126 and D2Mit185, in which Wt1 and Pax6 genes were involved. The genes flanking the SFFV proviral integration 1 (Sfpi1) were suggested to work tumor suppressive in leukemogenesis in accordance with the observation of homozygous deletion. Rithidech et al. reported another commonly deleted region on chromosome 2.
9) The interval was 4.6 cM between D2Mit272 and D2Mit394, in which Wt1 and Pax6 genes existed.
WAGR (Wilms' tumor, aniridia, genitourinary anomalies, mental retardation) syndrome is one of the well-known congenital disorders, patients of which have carried the simultaneous deletion of PAX6 and WT1 (OMIM#194072). Mouse small eye mutants, Pax6
Sey1H
, Pax6
Sey2H
, and Pax6
Sey3H are animal models of the WAGR syndrome, characterized by the genomic deletion at the two genes' locus and by the small eye phenotype.
10) It is of great interest whether the congenital deletion of Wt1 and Pax6 predisposes mice to acute myeloid leukemia. If deletion mutants developed acute myeloid leukemia, and if any mutation was found in the monoallelic genes of myeloid leukemia cells, it could be possible to identify the gene responsible for leukemogenesis. Therefore we have tested the susceptibility of Pax6
Sey3H to radiation by using the established system for the induction of acute myeloid leukemia.
11)

MATERALS AND METHODS
Mice
Frozen embryos of the Pax6
Sey3H hemizygous mutant were purchased from MRC (Harwell, OXON, UK), and mutants have been maintained by crossing with C3H/He (Charles River Japan Inc.). 12) Offspring from the third generation were used for experiments. F1 hybrids backcrossed with C57BL/ 6N, BALB/C (Charles River Japan Inc.), or JF1 (National Institute of Genetics, Mishima, Japan) were used for deletion mapping. Pax6
Sey3H mice of the 3rd and 4th generations (C3H × Pax6
Sey3H
) and F1 hybrid mice between Pax6
Sey3H and JF1 (JF1 × Pax6
) were used for the tumorigenesis experiment. Animal studies were carried out under guidance issued by the Research Institute for Radiation Biology and Medicine in Responsibility in the Use of Animals for Research.
Pax6
Sey3H was selected for testing because the deleted region was shortest among the three small eye mutants according to the previous report based on the cytogenetic examination.
10) The mutant with the shortest deletion was endowed with high fertility and viability. These two factors were very important for the completion of the carcinogenesis experiments using mutant mice.
Genotyping the mutant
DNA was prepared from the tail tips by use of a DNA rapid extraction kit (Qiagen, Hilden, Germany 12) Aliquots of the 10 micro l of products were separated by electrophoresis on the 3% agarose gel.
Tumorigenicity test
The gamma-irradiation emitted from the 60 Co source (Shimadzu, Japan) was performed on the whole body at the age of 10 weeks. The exposure was single with a dose of 3.0 Gy at a rate of 68.7 cGy/min.
11 ) The tumorigenicity has been observed for 24 months.
Histopathological analysis.
The mice were autopsied when moribund, exhibiting anemia with palpable spleens, or at the age of termination, 24 months. The main organs and tumor tissues were fixed in 10% phosphate-buffered formalin, dehydrated with alcohol, embedded in paraffin wax, sectioned 4 micro m thick, stained with hematoxylin and eosin, and observed pathologically. The intestines from stomach to colon were sliced into serial sections 4 micro m thick for the examination of tumor multiplicity.
A standard avidin-biotin complex technique was performed for the peroxidase in the hematopoietic tumor cells in liver. 13) Polyclonal antibodies to peroxidase (MBL Inc., Japan) were used as the primary antibody at a titer of 1:1000.
Statistical analysis
Survival curves were prepared by the Kaplan-Meier method.
14) The difference between survival curves was evaluated by use of the Log rank and Wilcoxson test. Survival proportions and incidences of tumors at the age of 24 months were compared statistically by a test of the difference between two proportions. 
RESULTS
Deletion region of the mutant
Deletion mapping was performed to define the deleted ends. The deleted segment was between markers D2Mit477 and D2Mit480 (Fig. 1) (Fig. 1 ).
Myeloid leukemogenicity of (C3H × Pax6
Sey3H ) mutants
Survival proportions at the age of 24 months were 0.57 and 0.88 for mutants and normal sibs, respectively, in non-treated groups ( Fig. 2-a) (not statistically significant). The final survival proportion for mutants (0.10) was not different from that of the normal sibs (0.05) in the gamma-irradiated groups. However, the survival curve of the mutants shifted toward the left with the higher decrease of survival proportion at young ages (p = 0.006 by the Wilcoxson test). There was no bias of sex on any survival curve in Fig 2-a. Mutant mice did not develop hematopoietic tumors spontaneously, but they did when γ-irradiated ( Table 1 ). The development of myeloid leukemia was radiation specific, and the final incidence of myeloid leukemia for mutants (25.8%) was as high as that for normal sibs (21.4%) ( Table 2 ). The cumulative survival curve of mutants bearing myeloid leukemias shifted toward the left when compared to that of normal sibs (p = 0.043 by the Log rank test) ( Table 3 ). The mean latencies of myeloid leukemia were 342.5 and 464.2 days for mutants and normal sibs, respectively.
There was no bias of sex on any survival curve; however, myeloid leukemias developed in female mutants with a high incidence (6 out of 8, or 75.0%) ( Table 4 ). The incidences of myeloid leukemia in a comparison between sex-adjusted and non-adjusted, values were similar. The mean latency of myeloid leukemia for female mutants (330.0 days) was short.
Myeloid leukemoginicity of (JF1 × Pax6
Sey3H ) mutants
The survival proportion of mutants was as high as that of normal sibs at the age of 24 months in the non-treated and gamma-irradiated groups (Fig. 2-b) . Spontaneous hematopoietic tumors were not observed ( Table 1 ). The incidences of myeloid leukemia were 6.7% and 3.6% for mutants and normal sibs, respectively, in the gamma-irradiated groups (Table  2) .
With regard to the genetic background in normal sibs, the survival proportion of gamma-irradiated (JF1 × Pax6
Sey3H
) at 24 months of age (0.57) was higher than that of irradiated (C3H × Pax6 Sey3H ) (0.05) (p < 0.00001 by a test of the differ- ence between two proportions) ( Fig. 2-a and b) . Also, the survival proportion of gamma-irradiated (JF1 × Pax6 Sey3H ) mutants (0.47) was higher than that of (C3H × Pax6 Sey3H ) (0.10) (p = 0.003 by a test of the difference between two proportions).
Intestinal tumorigenicity of the mutant
The mutants of (C3H × Pax6
Sey3H
) developed intestinal tumors spontaneously (Table 1) . Because these tumors were found at the age of 24 months without any clinical sign (3 of 4 cases, or 75%), the development of these tumors had no influence on the survival proportion. Radiation did not raise the incidence of intestinal tumors in mutants, nor did it induce the tumors in normal sibs (Table 1) . Tumor latencies were not comparable because the number of mice that developed the tumor before the age of 24 months was only one (Table 3) . Cumulative survival curves drawn by the Kaplan-Meier method with the parameter of intestinal tumors showed no statistically significant difference between the non-treated and the gamma-irradiated groups (data not shown).
In cases of the (JF1 × Pax6
) mutants, intestinal tumors were found when gamma-irradiated (Table 1 ). Three of 6 cases (50%) were found at 24 months of age with no clinical sign.
No case developed with both myeloid leukemia and intestinal tumors simultaneously (Table 1) .
DISCUSSION
After the complete sequence of mouse genome in 2002, it became possible to get the positional information for each gene or each STS marker on each chromosome (http:// www.ensembl.org/Mus_musculus/geneview). Table 5 summarizes the genomic information about the deleted segments of chromosome 2 associated with mouse acute myeloid leukemia. The congenitally deleted segment of Pax6
Sey3H was found to cover 15.4-25.6% of deleted segments reported in the radiation-induced myeloid leukemia. [7] [8] [9] Our result indicated that a congenital hemizygosity of the short segment of Pax6 Sey3H alone was not enough for the development of myeloid leukemias. When the hypothesis that the tumor suppressor gene controls the radiation-induced myeloid leukemogenesis is supported, no gene responsible for leukemogenesis is within the deleted region.
Another hypothesis for mouse radiation leukemogenesis is that the radiation-induced genetic instability is causal. [15] [16] [17] Under this viewpoint, the length of or genes in the hemizygous segment must be considerable. As the segment of 5.47 Mb occupied the utmost 3.02% of the whole genome of chromosome 2 (181.11 Mb), the length could be too short to force chromosomes unstable. There are several genes whose haploinsufficiency caused chromosomal instability. [18] [19] [20] The partial deletion of chromosome 2 observed in leukemia cells from mutant mice with a null mutation in one allele of the Trp53 gene could be explained as an example of chromosomal instability caused by the Trp53 haploinsufficiency (Table 5) . 16) It was unclear whether the shortening of leukemia latency observed in gamma-irradiated mutants was extraneous to or coincidental with the shortening of lifespans. However, when the values were compared by sex, a high incidence and a short latency of myeloid leukemia were found in female mutants. In consideration of the higher susceptibility in males than in females having resulted in the same system of radiationinduced myeloid leukemogenesis, 21) the cause of this reverse susceptibility in Pax6
Sey3H was speculated as follows.
Pax6
Sey3H mutants could be susceptible to radiation-induced myeloid leukemogenesis. A much higher frequency in male mutants than in females (31.6%) had been expected; however, it was inhibited by another factor, such as the epigenetic status of the chromosome. The deleted allele of Pax6
Sey3H was paternal in the present experiment. Therefore the epigenetic status of the monoallelic region as well as the whole chromosome 2 in mutants should be different from those in normal sibs.
Unfortunately, a trial to produce Pax6 Sey3H carrying the maternally transmitted mutated allele failed. Because the fer- tility of the Pax6 Sey3H female was very low, it took a long time to get a proper number of mutants for testing. Furthermore, the mortality of newborn mutants was high because of the growth retardation during embryogenesis. A kind of haploinsufficiency of the Fshb gene locating within the monoallelic segment (http://www.ensembl.org/Mus_musculus/geneview) must have had an influence on the reproductive system of female mutants. A preferential loss of maternally transmitted allele was reported in the CBA/H mouse model of radiationinduced acute myeloid leukemia. 22) The loss of imprinting of the insulin like growth factor II gene triggered acute myeloid leukemia. 23) The spontaneous development of intestinal tumors in Pax6
Sey3H was unique. There has been no report in which any of the six known genes in the deleted segment were associated with intestinal tumors. No gene whose mutations developed intestinal tumors spontaneously with a high frequency were located on chromosome 2 (Category of Mouse Tumor Biology, http://tumor.informatics.jax.org). [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Intestinal tumorigenesis was not promoted by radiation, although the age at exposure was unsuitable for the induction of solid tumors. It is conclusive that intestinal tumorigenesis of Pax6
Sey3H may be ignored in the discussion of myeloid leukemogenesis, which has been tested under the established system. Sey3H onto C3H/He and those onto JF1.
